Clinical and Translational Science Award (UM1 Clinical Trial Optional)
ID: 356316Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356316

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-272.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, aimed at enhancing clinical and translational research through collaborative partnerships. This initiative invites applications for hubs that will focus on improving the efficiency of clinical translation, addressing health disparities, and fostering innovative research methodologies, with a particular emphasis on community engagement and workforce development. Successful applicants, which may include higher education institutions and nonprofit organizations, are expected to outline strategic management and demonstrate strong leadership, with projects capped at seven years and a submission deadline of September 28, 2027. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the funding opportunity page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-272.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-272.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, aimed at accelerating clinical and translational research. The CTSA Program encourages applications for hubs that foster collaborative partnerships to streamline the development and dissemination of healthcare innovations across diverse communities. Key focus areas include enhancing research efficiency, addressing health disparities, and nurturing the capacity of clinical research professionals. The NOFO invites multiple types of applicants, notably higher education institutions and nonprofit organizations, with a project budget based on preceding NIH funding levels. Successful hub applications must outline strategic management, workforce development, community engagement, and innovative research methodologies with defined goals. Hubs are expected to not only conduct but also disseminate findings that contribute broadly to the translational science landscape. Applications are to be submitted by specific dates in 2025, with projects capped at seven years. This announcement reflects the NIH's commitment to improving healthcare outcomes through science, enhancing resource sharing and collaborative efforts within the CTSA consortium and beyond. Essential characteristics of successful hubs include strong leadership, institutional support, and a commitment to continuous quality improvement within the clinical research framework.
    Similar Opportunities
    Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards." This initiative aims to support the development and demonstration of innovative resources and capabilities within Clinical and Translational Science Awards (CTSA) Program hubs, specifically targeting critical gaps and roadblocks in clinical research. Successful applicants, who must be active UM1 CTSA award recipients, will propose projects lasting up to five years with an annual budget cap of $500,000, emphasizing collaboration and innovation in health research. Interested parties should note that the application deadline is September 14, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Clinical and Translational Science Award (UM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Clinical and Translational Science Award (CTSA) Program, specifically the UM1 Clinical Trial Optional grant. This initiative aims to enhance the efficiency of translating biomedical research into improved health outcomes by establishing national hubs for clinical and translational science, with a focus on fostering partnerships and developing innovative research programs to address health disparities. Applicants must submit a comprehensive plan that includes a required K12 Clinical Scientist Institutional Career Development Program application, as both applications must be submitted for the UM1 application to be reviewed. The deadline for submission is September 13, 2024, and interested parties can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-21-293.html.
    Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Clinical and Translational Science Award (CTSA) Program for the Collaborative and Innovative Acceleration Award (UG3/UH3), aimed at enhancing translational research via innovative collaborations. This initiative invites applications that focus on developing and demonstrating innovative solutions to address common inefficiencies in the translational research process, ultimately facilitating quicker access to health interventions for diverse populations, particularly underserved communities. With an anticipated annual funding commitment of up to $6 million and a project period not exceeding five years, eligible applicants include public and state-controlled institutions of higher education, as well as active CTSA hub organizations that must submit joint applications involving at least three eligible entities. Interested parties can find more information and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by October 17, 2024.
    Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Center for Advancing Translational Sciences (NCATS), has announced a funding opportunity titled "Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)." This initiative aims to enhance research education by supporting innovative programs that expose participants to the principles of translational science across various research stages, including pre-clinical and public health. Eligible organizations, particularly those serving underrepresented groups, may apply for funding of up to $100,000 per year for a maximum project period of five years, with applications required to include comprehensive plans for diversity recruitment and responsible conduct of research training. Interested applicants should note that the application deadline is September 13, 2024, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    Notice of Intent to Publish a Notice of Funding Opportunity for the Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to reissue a Notice of Funding Opportunity (NOFO) for the Clinical and Translational Science Award (CTSA) Program, aimed at establishing hubs that will contribute to a national consortium focused on accelerating the delivery of treatments to patients through advancements in clinical and translational science. This initiative is designed to foster meaningful collaborations and responsive projects among eligible applicants, which include various organizations and institutions. The anticipated NOFO is expected to be published in Summer 2024, with applications due by January 2025, and the estimated award date is set for December 16, 2025. Interested parties should prepare for the upcoming application process as no cost-sharing or matching is required for this cooperative agreement funding opportunity.
    Notice of Intent to Re-issue PAR-22-167 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to re-issue the Notice of Funding Opportunity Announcement (PAR-22-167) for the Clinical and Translational Science Award (CTSA) Program, specifically the Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional). This funding opportunity aims to foster meaningful collaborations and innovative projects in clinical and translational science, with no cost-sharing or matching requirements for eligible applicants, which include for-profit organizations. The estimated total program funding is $5 million, with an award ceiling of $650,000, and the NOFO is expected to be published in Fall 2024, with applications due in Winter 2025. Interested parties should prepare for the anticipated timeline, as the estimated project start date is December 1, 2025, and further details can be found on the CCIA webpage.
    Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition: Mentored Research Career Development Program Award under the Clinical and Translational Science Awards (CTSA) Program, aimed at supporting institutional research career development for postdoctoral fellows and junior faculty in clinical and translational science. Eligible organizations are required to submit both a K12 application and a companion UM1 application, with each institution allowed one K12 application, providing funding for scholars over a period of two to five years. This initiative is crucial for fostering a diverse and skilled workforce capable of advancing clinical and translational research, with a focus on developing competencies in teamwork, leadership, and communication. Interested applicants should note that the application deadline is September 13, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Notice of Intent to Publish a Notice of Funding Opportunity for the Re-issue of PAR-21-339 - Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to reissue a Notice of Funding Opportunity (NOFO) for the Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25), with a focus on educational activities that enhance research experiences in clinical and translational science. This initiative aims to support recipients of Clinical and Translational Science Awards (CTSA) by providing exposure to the scientific and operational principles of the translational process, covering areas such as pre-clinical research, clinical research, clinical implementation, and public health. The anticipated funding amount for this grant is up to $100,000, with the NOFO expected to be published in Summer 2024 and applications due by January 27, 2025. For further details, potential applicants are encouraged to prepare their proposals in advance of the expected award date on December 16, 2025.
    Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program, designated as R03 Clinical Trial Optional. This funding opportunity aims to support KL2/K12 scholars and recipients of diversity and re-entry supplements in their transition to independent research roles by funding small, innovative, self-contained projects in translational science, with a maximum budget of $50,000 per year over a two-year period. The initiative is designed to enhance the capabilities of emerging researchers in addressing inefficiencies in translating research into clinical applications, engaging underrepresented populations, and improving data accessibility through innovative technologies. Applications will be accepted starting January 19, 2024, with multiple deadlines leading up to October 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant under the Clinical and Translational Science Awards (CTSA) Program, aimed at enhancing postdoctoral training at eligible institutions. This limited competition grant seeks to equip individuals with health professional degrees with the necessary skills and knowledge to advance health diagnostics, therapeutics, and clinical interventions, while fostering a diverse pool of clinical and translational scientists. The program allows for project durations of up to five years, contingent on NIH appropriations, and emphasizes the importance of diversity, interdisciplinary collaboration, and effective mentoring practices. Interested applicants can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with the application deadline set for September 13, 2024.